| Name | Title | Contact Details |
|---|
Radiology Associates of North Texas is a private practice provider of high quality diagnostic and interventional radiology services. With over 240 Texas based radiologists, our practice provides a level of service and subspecialty expertise to North Te...
Founded in 1987, Health Level Seven (HL7) is an ANSI-accredited non-profit that empowers global health data interoperability by developing standards and enabling their adoption and implementation – for a world where everyone can securely access and use the right health data when and where they need it.
Angels Harbor is a residential treatment facility located in Vincent, Ohio that offers inpatient residential treatment services to women struggling with substance use.
Gateway Health is a nationally ranked managed care organization that focuses on providing the best possible healthcare to a growing number of Medicaid and Medicare Advantage consumers. A not-for-profit organization, Gateway Health serves the needs of at risk and vulnerable citizens with not only healthcare coverage, but services such as disease management, health and wellness programs and preventive care. The organization provides Medicaid services in Pennsylvania, Delaware, Arkansas and West Virginia and Medicare coverage in Pennsylvania, Kentucky, Ohio and North Carolina. Our commitment to helping our members and their communities get and stay healthy is what keeps members, providers, communities and partners Good with Gateway.
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.